Clinical Trials
73 trialsCAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
Qurgen Inc.
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
PITHAC
Centre Hospitalier Universitaire Vaudois
Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376
National Cancer Centre, Singapore
To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer.
Changchun GeneScience Pharmaceutical Co., Ltd.
Mass Balance Study of TQB3616
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Minnelide 101
Minneamrita Therapeutics LLC
CAT_PB
Lebanese University
IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
QUEST
National University Hospital, Singapore
Study of SHR6390 in Renal Insufficiency and Healthy Subjects
Jiangsu HengRui Medicine Co., Ltd.
WEE1
Impact Therapeutics, Inc.
A Double-Blind, Comparative, Randomized Clinical Study of the Pharmacokinetics, Safety, and Immunogenicity of a Single Intravenous Infusion of BCD-178 or Perjeta® in Healthy Volunteers
Biocad
A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer
Shanghai Proton and Heavy Ion Center
GEN602
Genzada Pharmaceuticals USA, Inc.
A Study of TY-302 in Patients With Advanced Solid Tumors
TYK Medicines, Inc
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Provectus Pharmaceuticals
A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
MICROBIOME
Imperial College London
A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors
Silverback Therapeutics
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
TMBA
Universitair Ziekenhuis Brussel
A Study for Optimization of 6% Hydroxyethyl Starch Based Indocyanine Green Near-infrared Fluorescence Navigated Sentinel Lymph Node Biopsy for Breast Cancer Patients
National Taiwan University Hospital Hsin-Chu Branch
Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer
Zhejiang Provincial People's Hospital
Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer
Hoffman Oncology
KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors
ISU Abxis Co., Ltd.
Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors
Peking University Cancer Hospital & Institute
i-GO
UMC Utrecht
Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors
Hengrui Therapeutics, Inc.
Reconstruction of Partial Mastectomy Defects With Pectoralis Myo-glandular Local Flap.
Mansoura University
Complementary and Alternative Medicine on Mental Health in Breast Cancer Patients
Klaipėda University
Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer
Al-Azhar University
Study of EOC317 in Chinese Patients With Advanced Solid Tumors
Taizhou EOC Pharma Co., Ltd.
A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations
Placon Therapeutics
Safety Assessment of Repeated Administration of TK006 in Patients With Breast Cancer-related Bone Metastases
Jiangsu T-Mab Biopharma Co.,Ltd
Preoperative Localization of Sentinel Lymph Node in Breast Cancer Patients By Novel Computed Tomography-Lymphography Guided Technique
Mansoura University
Capecitabine
Qilu Pharmaceutical Co., Ltd.
Assessment of TK006 in Patients With Breast Cancer-related Bone Metastases
Jiangsu T-Mab Biopharma Co.,Ltd
Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer
Jiangsu T-Mab Biopharma Co.,Ltd
Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Metastatic Triple Negative Breast Cancer
Fudan University
A Clinical Research of CAR T Cells Targeting CEA Positive Cancer
Southwest Hospital, China
Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Wuxi No. 4 People's Hospital
BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast Cancer
R-Pharm
Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
Merrimack Pharmaceuticals
Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans
Rigshospitalet, Denmark
T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies
Shenzhen Second People's Hospital
Cancer Prevention in Women With a BRCA Mutation
Women's College Hospital